Before we get into the good stuff, let's talk about what we're actually dealing with here
A nanotheranostics with hypoxia-switchable fluorescence and photothermal effect for hypoxia imaging-guided immunosuppressive tumor microenvironment modulation
Anti-emetic and emetic effects of erythromycin in Suncus murinus: role of vagal nerve activation, gastric motility stimulation and motilin receptors
Most people at standard doses (222 mg, 3/week) do not develop liver problems
1 The company is positioning the move as a direct response to structural cost issues in the current system, which, as Arpit Patel, senior vice president of Trade Relations and Supply Chain, noted, remains unnecessarily complex and expensive. 1 This move comes at a time when 2 The financial pressure on employer health plans has intensified as GLP-1 medications move from being primarily used for type 2 diabetes to widespread use for weight management
The year 2021 witnessed a staggering 529 million diagnosed cases of diabetes, with projections indicating a substantial increase to over 1.31 billion cases by the year 2050 ( GLP-1 RAs are experiencing expanded global utilization and favorable market potential
)
